z-logo
Premium
P98: Dose‐response and optimal administration timing of a new anti‐IL‐1 therapeutic, rytvela, for prevention of preterm birth and fetal injury
Publication year - 2021
Publication title -
american journal of reproductive immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.071
H-Index - 97
eISSN - 1600-0897
pISSN - 1046-7408
DOI - 10.1111/aji.96_13420
Subject(s) - medicine , administration (probate law) , fetus , obstetrics , anesthesia , pregnancy , pharmacology , biology , political science , law , genetics

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom